Industry
Biotechnology
Topic
Investments
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Investments in Biotechnology
... Harpoon Therapeutics, a biotechnology company developing novel T-cell recruiting biologic therapies for the ...
... recent years to sell thousands of genetic health tests, ranging from Google-backed 23andMe to Roche. But the consumers who order the tests often face months-long ...
... Symic Bio, a biopharmaceutical company developing novel matrix regulator therapeutics, today announced the ...
... Dublin-based Iterum Therapeutics Ltd, a clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives, has secured ...
... round raising $65 million. The financing was led by new investor Arix Bioscience plc, and included Pivotal bioVenture Partners, Advent Life Sciences, Domain Associates and ...
... Sharklet Technologies, Inc., a biotechnology company lauded for the creation and commercialization of Sharklet®, ...
... microbiome modulation platform technologies. BiomX, previously named MBcure, was founded in the FutuRx Ltd. incubator, with the support of the Israel Innovation Authority. "We are ...
... by the U.S. FDA regarding device-related questions and comments pertaining to its VGX-3100 phase 3 program. Inovio's new CELLECTRA® 5PSP commercial delivery device has been ...
... a Phase 2 study of StrataGraft, the skin tissue developed by Madison-based Stratatech, now part of Mallinckrodt, a global pharmaceutical company. The study is expected ...
... Lantern Pharma Inc, a clinical-stage biotech company, has raised $3.7 million in Series A ...
... Today Lantern Pharma Inc. announced the closure of its Series A equity financing of $3.7 ...
... positive early results from its ad tests. 6. Gett confirms acquisition of Juno More consolidation in the ride-sharing space occurred as on-demand ride sharing company ...
... Juno always had the best sales pitch. The company started in New York ...
... Waltham, Massachusetts-based Arsanis Inc, a developer of targeted monoclonal antibodies for treating serious infectious diseases, ...
... 25, 2017( VentureBeat: http://venturebeat.com / Delivered by Newstex) Clinical trial technology company Science 37[1] has raised $29 million in a Series C round of funding ...
... profiles 41 companies including many key and niche players such as -- 23andMe, Inc. - Color Genomics, Inc. - Any Lab Test Now - Ancestry.com, ...
... South San Francisco-based Circle Pharma, a developer of macrocyclic peptide therapeutics, has raised about $6.5 million ...
... Science 37, a trailblazing company focused on "site-less" clinical trials, announced today $29 ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start Your Free Trial ➤